<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04867044</url>
  </required_header>
  <id_info>
    <org_study_id>2017-KAEK-189_2021.03.10_17</org_study_id>
    <nct_id>NCT04867044</nct_id>
  </id_info>
  <brief_title>Prevalence of Temporomandibular Disorders in Patients With Fibromyalgia Syndrome</brief_title>
  <official_title>Prevalence of Temporomandibular Disorders in Patients With Fibromyalgia Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yerkoy State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yerkoy State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One Hundred Fifty woman patients diagnosed with fibromyalgia according to the American&#xD;
      College of Rheumatology 2010 diagnostic criteria and 150 healthy woman volunteers will be&#xD;
      included.Demographic data (age, gender, height, weight, marital status, education level) and&#xD;
      duration of fibromyalgia diagnosis will be recorded. Patients will be evaluated according to&#xD;
      the Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments (DCTMD: AI ).&#xD;
      Patients will be evaluated by Diagnostic Criteria for Temporomandibular Disorders:&#xD;
      Temporomandibular Disorders (TMD) Pain Screener, Symptom questionnaire, Clinical Examination&#xD;
      Form from Assessment Instruments Axis I. Pain Drawing, Graded Chronic Pain (version 2), Jaw&#xD;
      Functional Limitation Scale-8 (JFLS-8), Patient Health Questionnaire (PHQ-4), Oral Behaviors&#xD;
      Checklist will be applied within the scope of Axis II.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In our study, the investigators aim to compare the frequency of temporomandibular disorders&#xD;
      between healthy female participants and female patients diagnosed with fibromyalgia.&#xD;
&#xD;
      Our study will consists of 300 female participants aged between 18 and 65 years who applied&#xD;
      to the physical therapy and rehabilitation outpatient clinic between May 2021 and August&#xD;
      2021. This case-control study will conducted according to the Declaration of Helsinki.&#xD;
      Participants gave written voluntary consent and enrolled in this case-control study. One&#xD;
      Hundred Fifty woman patients diagnosed with fibromyalgia according to the American College of&#xD;
      Rheumatology 2010 diagnostic criteria and 150 healthy woman volunteers will be included.&#xD;
      Patients with temporomandibular region surgery, congenital teporomandibular joint&#xD;
      pathologies, and previous temporomandibular region trauma were will be excluded from the&#xD;
      study. Because fibromyalgia is a disease that mostly affects women, the investigators&#xD;
      designed our study so that all participants were women. In addition, demographic data (age,&#xD;
      gender, height, weight, marital status, education level) and duration of fibromyalgia&#xD;
      diagnosis will be recorded. Patients will be evaluated according to the Diagnostic Criteria&#xD;
      for Temporomandibular Disorders: Assessment Instruments ( DCTMD: AI ). Patients will be&#xD;
      evaluated by Diagnostic Criteria for Temporomandibular Disorders: TMD Pain Screener, Symptom&#xD;
      questionnaire, Clinical Examination Form from Assessment Instruments Axis I. Pain Drawing,&#xD;
      Graded Chronic Pain (version 2), Jaw Functional Limitation Scale-8 (JFLS-8), Patient Health&#xD;
      Questionnaire (PHQ-4),Oral Behaviors Checklist will be applied within the scope of Axis II.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">June 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>DCTMD: AI Axis I Pain Screener</measure>
    <time_frame>0 DAY</time_frame>
    <description>TMD Pain Screener which is a simple, reliable, and valid self-report instrument used to assess for the presence of any pain-related TMD, with sensitivity and specificity ≥ 0.95 which is recommended for all patients in any clinical setting. A positive screen is followed by further evaluation to arrive at the specific TMD pain-related diagnoses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DCTMD: AI Axis I Symptom questionnaire</measure>
    <time_frame>0 DAY</time_frame>
    <description>Symptom questionnaire which assess pain characteristics as well as history of jaw noise, jaw locking, and headache.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DCTMD: AI Axis I Clinical Examination Form</measure>
    <time_frame>0 DAY</time_frame>
    <description>Clinical Examination Form- The clinical examination includes provocation tests for TMJ arthralgia of pain with any jaw movement (ie, opening, lateral, and protrusive) and TMJ palpation. For myalgia, the tests include pain with opening jaw movements and palpation of the temporalis and masseter muscles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DCTMD: AI Axis II-Pain Drawing</measure>
    <time_frame>0 DAY</time_frame>
    <description>Pain Drawing-pain drawing of the head, jaw, and body, and it allows the patient to report the location of all pain complaints</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DCTMD: AI Axis II-Graded Chronic Pain (version 2)</measure>
    <time_frame>0 DAY</time_frame>
    <description>Graded Chronic Pain (version 2) is a short, reliable, and valid instrument that assesses pain intensity and pain-related disability.10 The two GCPS subscales are: Characteristic Pain Intensity (CPI), which reliably measures pain intensity, with ≥ 50/100 considered &quot;high intensity,&quot; and the pain-disability rating, which is based on number of days that pain interferes with activity and on extent of interference with social, work, or usual daily activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DCTMD: AI Axis II-Jaw Functional Limitation Scale-8 (JFLS-8)</measure>
    <time_frame>0 DAY</time_frame>
    <description>Jaw Functional Limitation Scale-8 (JFLS-8) which assesses global limitations across mastication, jaw mobility, and verbal and emotional expression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DCTMD: AI Axis II-Patient Health Questionnaire (PHQ-4)</measure>
    <time_frame>0 DAY</time_frame>
    <description>Patient Health Questionnaire (PHQ-4) is a short, reliable, and valid screening instrument for detecting &quot;psychological distress&quot; due to anxiety and/or depression in patients in any clinical setting.A cutoff of &gt; 6, suggesting moderate psychological stress, should be interpreted as warranting observation, while a cutoff of &gt; 9, suggesting severe psychological distress, should be interpreted as warranting either further assessment or referral</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DCTMD: AI Axis II- Oral Behaviors Checklist (OBC)</measure>
    <time_frame>0 DAY</time_frame>
    <description>Oral Behaviors Checklist (OBC), which assesses the frequency of oral parafunctional behaviors.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Temporomandibular Disorder</condition>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>STUDY GROUP</arm_group_label>
    <description>patient diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <description>healthy women volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>STUDY</intervention_name>
    <description>One Hundred Fifty woman patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010 diagnostic criteria</description>
    <arm_group_label>STUDY GROUP</arm_group_label>
    <other_name>Fibromiyalgia Patient</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>healthy woman volunteers</description>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <other_name>healthy participant</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Our study consists of 300 female participants aged between 18 and 65 years who applied to&#xD;
        the physical therapy and rehabilitation outpatient clinic.. One Hundred Fifty woman&#xD;
        patients diagnosed with fibromyalgia according to the American College of Rheumatology 2010&#xD;
        diagnostic criteria and 150 healthy woman volunteers were included.Because fibromyalgia is&#xD;
        a disease that mostly affects women, we designed our study so that all participants were&#xD;
        women.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  One hundred fifty woman patients diagnosed with fibromyalgia according to the American&#xD;
             College of Rheumatology 2010 diagnostic criteria&#xD;
&#xD;
          -  One hundred fifty womanhealthy volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with temporomandibular region surgery&#xD;
&#xD;
          -  Congenital teporomandibular joint pathologies&#xD;
&#xD;
          -  Previous temporomandibular region trauma were excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Our study consists of 300 female participants aged between 18 and 65 years</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Basak Cigdem karacay</name>
      <address>
        <city>Yozgat</city>
        <state>Yerkoy</state>
        <zip>66900</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basak Cigdem karacay, Spesialist</last_name>
      <phone>+903545162470</phone>
      <phone_ext>4003</phone_ext>
      <email>basakcigdem@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Basak Cigdem karacay, Spesialist</last_name>
      <phone>05466772966</phone>
      <email>basakcigdem@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Basak Cigdem karacay, spesialist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Basak CigdemKaracay</name>
      <address>
        <city>Yozgat</city>
        <state>Yerkoy</state>
        <zip>66900</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basak CigdemKaracay, Spesialist</last_name>
      <phone>+903545162470</phone>
      <phone_ext>4003</phone_ext>
      <email>basakcigdem@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Basak CigdemKaracay, Spesialist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Moreno-Fernández AM, Jiménez-Castellanos E, Iglesias-Linares A, Bueso-Madrid D, Fernández-Rodríguez A, de Miguel M. Fibromyalgia syndrome and temporomandibular disorders with muscular pain. A review. Mod Rheumatol. 2017 Mar;27(2):210-216. doi: 10.1080/14397595.2016.1221788. Epub 2017 Feb 1. Review.</citation>
    <PMID>27539739</PMID>
  </reference>
  <reference>
    <citation>Fujarra FJ, Kaziyama HH, Siqueira SR, Yeng LT, Camparis CM, Teixeira MJ, Siqueira JT. Temporomandibular disorders in fibromyalgia patients: are there different pain onset? Arq Neuropsiquiatr. 2016 Mar;74(3):195-200. doi: 10.1590/0004-282X20160017.</citation>
    <PMID>27050847</PMID>
  </reference>
  <reference>
    <citation>Pimentel MJ, Gui MS, Martins de Aquino LM, Rizzatti-Barbosa CM. Features of temporomandibular disorders in fibromyalgia syndrome. Cranio. 2013 Jan;31(1):40-5.</citation>
    <PMID>23461261</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yerkoy State Hospital</investigator_affiliation>
    <investigator_full_name>Başak Çiğdem Karaçay</investigator_full_name>
    <investigator_title>Spesialist</investigator_title>
  </responsible_party>
  <keyword>fibromiyalgia syndrome</keyword>
  <keyword>Temporomandibular Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

